ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-?B/ALDH1A3 Axis

Shi, Zhong-Fang; Li, Guan-Zhang; Zhai, You; Pan, Chang-Qing; Wang, Di; Yu, Ming-Chen; Liu, Chi; Zhang, Wei; Yu, Xiao-Guang*哈尔滨医科大学
Genes2023-3DOI: 10.3390/genes14030651
3被引14阅读
引用收藏
分享

摘要

(1) Background: Glioblastoma multiforme (GBM) is the most common and malignant intracranial tumor in adults. At present, temozolomide (TMZ) is recognized as the preferred chemotherapeutic drug for GBM, but some patients have low sensitivity to TMZ or chemotherapy resistance to TMZ. Our previous study found that GBM patients with EGFRvIII (+) have low sensitivity to TMZ. However, the reasons and possible mechanisms of the chemoradiotherapy resistance in GBM patients with EGFRvIII (+) are not clear. (2) Methods: In this study, tissue samples of patients with GBM, GBM cell lines, glioma stem cell lines, and NSG mice were used to explore the causes and possible mechanisms of low sensitivity to TMZ in patients with EGFRvIII (+)-GBM. (3) Results: The study found that EGFRvIII promoted the proneural-mesenchymal transition of GBM and reduced its sensitivity to TMZ, and EGFRvIII regulated of the expression of ALDH1A3. (4) Conclusions: EGFRvIII activated the NF-?B pathway and further regulated the expression of ALDH1A3 to promote the proneural-mesenchymal transition of GBM and reduce its sensitivity to TMZ, which will provide an experimental basis for the selection of clinical drugs for GBM patients with EGFRvIII (+).

学科与关键词

关键词
glioblastomaEGFRvIIINF-kappa Bproneural-mesenchymal transitiontemozolomide
相关
加载中…
  • Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway
    Tang, Qingfa; Cao, Haihong; Tong, Ni; Liu, Yuanliang; Wang, Wanyu; Zou, Yuheng; Xu, Lanyang; Zeng, Zhiyun; Xu, Wei; Yin, Zhixin; Ma, Wenjuan*; Wang, Qirui*PHYTOMEDICINE, 2022, 99: 154016.被引 17
  • Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
    Gu, Qiang; Li, Lang; Yao, Jiahao; Dong, Fa-yan; Gan, Yifan; Zhou, Shuhuai; Wang, Xinyu; Wang, Xue-feng*Frontiers in Oncology, 2023, 13: 1120103.
  • IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma
    Zhang, Xuehua; Wang, Guoyan; Gong, Yujiao; Zhao, Leilei; Song, Ping; Zhang, He; Zhang, Yurui; Ju, Huanyu; Wang, Xiaoyu; Wang, Bin; Ren, Huan*; Zhu, Xiao*; Dong, Yucui*iScience, 2023, 26(5): 106639.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Genes
发表日期
2023-03
卷期
第 14 卷, 第 3 期
页码
651
DOI
10.3390/genes14030651
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072768]; Medical and Health Technology Innovation Project of the Chinese Academy of Medical Sciences [2020-I2M-CT-A-024]; Sino-German Center Cooperation and Exchanges Program [M-0020]; public welfare development and reform pilot project of Beijing Medical Research Institute [JYY 2022-7]

作者

  • S

    Shi, Zhong-Fang (第一作者)

    beijing neurosurg inst · capital med univ · harbin med univ

  • L

    Li, Guan-Zhang

    capital med univ

查看全部 9 位作者收起作者
  • Z

    Zhai, You

    capital med univ

  • P

    Pan, Chang-Qing

    capital med univ

  • W

    Wang, Di

    capital med univ

  • Y

    Yu, Ming-Chen

    capital med univ

  • L

    Liu, Chi

    harbin med univ

  • Z

    Zhang, Wei

    capital med univ

  • Y

    Yu, Xiao-Guang (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417